Travere Therapeutics, Inc. · NASDAQ:TVTX
Baynes Roy D. sold 9,750 Travere Therapeutics, Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 4, 2026
On May 1, 2026, Baynes Roy D. (Director) sold 9,750 Travere Therapeutics, Inc. shares at US$44.22 for US$431K under a trading plan, leaving 37,500 shares. Filed May 4, 2026 (Form 4).
- Sold
- 9,750 shares
- Price
- US$44.22
- Value
- US$431K
- Holding after
- 37,500 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Option exercise | 9,750 | US$6.82 | 47,250 | Direct |
| May 1, 2026 | Common Stock | Sale | 9,750 | US$44.22 | 37,500 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Baynes Roy D.
- Travere Therapeutics, Inc. shareholders
- Form 4 · Baynes Roy D. · Jun 16, 2026
- Form 4 · Baynes Roy D. · May 21, 2026
- Form 4 · Baynes Roy D. · May 6, 2026
- Form 4 · Baynes Roy D. · Apr 16, 2026
- Form 4 · Baynes Roy D. · Apr 7, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026